Print

COVID-19 Updates

 

S. No.

Title

1.       

Advisory for reporting Adverse Events/Adverse Drug Reactions due to use of Hydroxychloroquine as prophylaxis for SARS-CoV-2 infection (COVID-19)

2.       

Suspected Adverse Drug reaction Reporting Form (FOR DRUGS USED IN PROPHYLAXIS/TREATMENT OF COVID-19)

3.       

IPC Notice Regarding Hydroxychloroquine Sulphate IPRS

4.       

Standards of  Drugs available in Indian Pharmacopoeia Commission for the drugs being used for COVID-19 Prophylaxis

5.       

Indian Pharmacopoeia monographs for herbal Drugs and Phytochemical reference standards available at Indian Pharmacopoeia Commission as per advisory given by Ministry of AYUSH

6.       

Medical Devices Adverse Event Reporting Form Including reporting of (False Positive/False Negative) In-vitro Diagnostic Kits.

7.       

With reference to the OFFICE MEMORANDUM NO. 11013/9/2014-ESTT (A.III) dated 29-04-2020 issued by M/o Personnel, Public Grievance and Pensions, Department of Personnel & Training, New Delhi. IPC also issued an order no. IPC/1064/2020-21 for effective use of ‘Aarogyasetu’ app for breaking the chain of transmission of COVID-19.

8.

Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection (in supersession of previous advisory dated 23rd March, 2020)